Skip to content
FDA drug shortage status

Is Icatibant Acetate Injection in shortage?

Icatibant Acetate Injection is listed by FDA as being discontinued by at least one maker (updated May 7, 2026).

Being discontinuedFDA status
2packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86)
    Fresenius Kabi USA, LLCBeing discontinuedUpdated May 7, 2026Discontinued May 7, 2026

    Discontinuation of the manufacturer of the drug

    Maker contact: 847-550-2300

  • Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93)
    Fresenius Kabi USA, LLCBeing discontinuedUpdated May 7, 2026Discontinued May 7, 2026

    Discontinuation of the manufacturer of the drug

    Maker contact: 847-550-2300

Icatibant Acetate Injection shortage questions

Is Icatibant Acetate Injection in shortage?

Icatibant Acetate Injection is listed by FDA as being discontinued by at least one maker (updated May 7, 2026).

What should I do if I can’t get Icatibant Acetate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.